2011Chinese Journal of General PracticeRequires access

Observation of Clinical Effect of Carvedilol in the Treatment of Chronic Heart Failure

Yao Pen

Open publisher page 0 citations

Abstract

Objective To observe clinical effect and safety of Carvedilol in the treatment of chronic congestive heart failure.Methods 75 cases of chronic congestive heart failure were randomly divided into two groups: treatment group(n=38) and control group(n=37).All patients were treated with ACEI,diuretics,digoxin and nitrate,the treatment group was additionally given carvedilol,from small doses of 2.5 mg gradually increased to the maximum tolerated dose for the maintenance of the amount for treatment of 6 months.After 6 months,cardiac function,left ventricular diastolic volume,ejection fraction was observed.Results After treatment of 6 months,all patients cardiac function changed significantly(P0.05);Compared with the control group,LVEDD decreased(P0.01) and LVEF(%) increased(P0.01)in the treatment group.The difference had statistical significance.Conclusion Carvedilol was both α1 and β adrenergic receptor blocker,low-dose therapy significantly increased cardiac function in patients with chronic heart failure,it was safe and reliable.

About this research paper

What this paper is about

Objective To observe clinical effect and safety of Carvedilol in the treatment of chronic congestive heart failure.Methods 75 cases of chronic congestive heart failure were randomly divided into two groups: treatment group(n=38) and control group(n=37).All patients were treated with ACEI,diuretics,digoxin and nitrate,the treatment group was additionally given carvedilol,from small doses of 2.5 mg gradually increased to the maximum tolerated dose for the maintenance of the amount for treatment of 6 months.After 6 months,cardiac function,left ventricular diastolic volume,ejection fraction was observed.Results After treatment of 6 months,all patients cardiac function changed significantly(P0.05);Compared with the control group,LVEDD decreased(P0.01) and LVEF(%) increased(P0.01)in the treatment group.The difference had statistical significance.Conclusion Carvedilol was both α1 and β adrenergic receptor blocker,low-dose therapy significantly increased cardiac function in patients with chronic heart failure,it was safe and reliable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe clinical effect and safety of Carvedilol in the treatment of chronic congestive heart failure.Methods 75 cases of chronic congestive heart failure were randomly divided into two groups: treatment group(n=38) and control group(n=37).All patients were treated with ACEI,diuretics,digoxin and nitrate,the treatment group was additionally given carvedilol,from small doses of 2.5 mg gradually increased to the maximum tolerated dose for the maintenance of the amount for treatment of 6 months.After 6 months,cardiac function,left ventricular diastolic volume,ejection fraction was observed.Results After treatment of 6 months,all patients cardiac function changed significantly(P0.05);Compared with the control group,LVEDD decreased(P0.01) and LVEF(%) increased(P0.01)in the treatment group.The difference had statistical significance.Conclusion Carvedilol was both α1 and β adrenergic receptor blocker,low-dose therapy significantly increased cardiac function in patients with chronic heart failure,it was safe and reliable.

Key concepts: Carvedilol, Medicine, Ejection fraction, Heart failure, Digoxin, Cardiology, Internal medicine, Cardiac function curve

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of Clinical Effect of Carvedilol in the Treatment of Chronic Heart Failure — Research Paper | ScholarLens